Skip to main content

Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture?

Publication ,  Journal Article
Armstrong, AJ; Eisenberger, M
Published in: Nat Clin Pract Urol
May 2006

Duke Scholars

Published In

Nat Clin Pract Urol

DOI

ISSN

1743-4270

Publication Date

May 2006

Volume

3

Issue

5

Start / End Page

246 / 247

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., & Eisenberger, M. (2006). Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture? Nat Clin Pract Urol, 3(5), 246–247. https://doi.org/10.1038/ncpuro0462
Armstrong, Andrew J., and Mario Eisenberger. “Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture?Nat Clin Pract Urol 3, no. 5 (May 2006): 246–47. https://doi.org/10.1038/ncpuro0462.
Armstrong AJ, Eisenberger M. Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture? Nat Clin Pract Urol. 2006 May;3(5):246–7.
Armstrong, Andrew J., and Mario Eisenberger. “Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture?Nat Clin Pract Urol, vol. 3, no. 5, May 2006, pp. 246–47. Pubmed, doi:10.1038/ncpuro0462.
Armstrong AJ, Eisenberger M. Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture? Nat Clin Pract Urol. 2006 May;3(5):246–247.

Published In

Nat Clin Pract Urol

DOI

ISSN

1743-4270

Publication Date

May 2006

Volume

3

Issue

5

Start / End Page

246 / 247

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences